256 related articles for article (PubMed ID: 17706036)
1. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].
Inukai T; Sugita K; Goi K; Akahane K; Hirose K; Nemoto A; Takahashi K; Sato H; Uno K; Furuichi Y; Nakamura M; Miyamoto N; Yamakawa N; Shiraishi K; Kojika S; Tezuka T; Iijima K; Nakazawa S
Rinsho Ketsueki; 2004 Apr; 45(4):297-303. PubMed ID: 15168445
[TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
Song CY; Li YH; Guo KY; Wu BY
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
5. [Low dose heparin for the prevention of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation].
Chen J; Zhu KE; Zhang T; Zhong J; Chen ST; Zeng HL
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):140-2. PubMed ID: 17445443
[TBL] [Abstract][Full Text] [Related]
6. [Preventive effect of integrated Chinese and Western medicine on hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Liu J; Zhang X; Chen XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Oct; 30(10):1049-51. PubMed ID: 21066888
[TBL] [Abstract][Full Text] [Related]
7. [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].
Dong M; Lin Q; Wu XY
Ai Zheng; 2008 Jun; 27(6):646-9. PubMed ID: 18570742
[TBL] [Abstract][Full Text] [Related]
8. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
[TBL] [Abstract][Full Text] [Related]
10. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Qin CJ; Liu LJ; Zhang ZM; Luo L; Lai YR; Li QC
Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):483-486. PubMed ID: 29996265
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation.
Schechter T; Finkelstein Y; Doyle J; Verjee Z; Moretti M; Koren G; Dupuis LL
Biol Blood Marrow Transplant; 2007 Mar; 13(3):307-14. PubMed ID: 17317584
[TBL] [Abstract][Full Text] [Related]
12. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Kallianpur AR; Hall LD; Yadav M; Byrne DW; Speroff T; Dittus RS; Haines JL; Christman BW; Summar ML
Bone Marrow Transplant; 2005 Jun; 35(12):1155-64. PubMed ID: 15834437
[TBL] [Abstract][Full Text] [Related]
13. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Cacchione A; LeMaitre A; Couanet DV; Benhamou E; Amoroso L; Simonnard N; Hartmann O
Bone Marrow Transplant; 2008 Oct; 42(7):449-54. PubMed ID: 18587430
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Park SH; Lee MH; Lee H; Kim HS; Kim K; Kim WS; Jung CW; Im YH; Yoon SS; Kang WK; Park K; Park CH; Kim SW
Bone Marrow Transplant; 2002 Jan; 29(2):137-43. PubMed ID: 11850708
[TBL] [Abstract][Full Text] [Related]
16. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Tefferi A; Kumar S; Wolf RC; Lacy MQ; Inwards DJ; Gloor JM; Albright RC; Kamath PS; Litzow MR
Bone Marrow Transplant; 2001 Nov; 28(10):997-9. PubMed ID: 11753559
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.
Méresse V; Hartmann O; Vassal G; Benhamou E; Valteau-Couanet D; Brugieres L; Lemerle J
Bone Marrow Transplant; 1992 Aug; 10(2):135-41. PubMed ID: 1525602
[TBL] [Abstract][Full Text] [Related]
18. [Allogeneic peripheral blood stem cell transplantation for 3 patients with beta-thalassemia major and 1 patient with congenital idiopathic haemolytic anemia].
Fang J; Huang S; Chen C; Wu Y; Bao R; Huang K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):452-5. PubMed ID: 11774214
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors.
Bouligand J; Le Maitre A; Valteau-Couanet D; Grill J; Drouard-Troalen L; Paci A; Hartmann O; Benhamou E; Vassal G
Clin Pharmacol Ther; 2007 Oct; 82(4):402-9. PubMed ID: 17392724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
